MITA Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner


MITA Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner

Washington, D.C. – Today, the Medical Imaging & Technology Alliance (MITA) issued the following statement from Executive Director Patrick Hope:

“MITA congratulates Dr. Scott Gottlieb on his confirmation as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), which plays a critical role in assuring the quality and safety of medical imaging equipment for patients. We have a long history of collaboration with the FDA to advance the innovation of medical imaging technologies, while ensuring patients have timely access to safe and effective medical devices. In particular, we look forward to working with Dr. Gottlieb on the implementation of MDUFA IV and minimum quality, safety and regulatory requirements for all medical device service providers.”



The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for advanced medical imaging. For more information, visit Follow MITA on Twitter @MITAToday.

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More